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Results: Pts with angina and NCA had decreased Ao strain and Ao dis and
increased Ao stiffness compared with control subjects: Ao Strain 17,7±7,4%
vs 24,8±10,8% (p=0,05), Ao Dis 078 ±0,3 vs 1,2±0,6cm2/dyne (p<0,05), Ao
SI 3,4±1,8 vs 1,9 ±0,5 (p<0,05).
TdI Ao wall velocity were decreased in pts group: SW 6,7±1,6 vs 10±1,9
cm/s, (p<0,05, Anova), EW 5,6±2,1 vs 9,4±2,7 cm/s (p<0,05), AW 7,1±2,3 vs
7,7±2,9 cm/s (p=0,4).
Ea and SVRI were increased and Ca decreased in patients with angina: Ea
2,1±0,5 vs 1,6±0,2 mmHg/ml (p<0,05), SVRI 2,9±0,8 vs 1,9±0,2 dyne *s
*m2/cm-5 (p<0,05), Ca 1,2±0,4 vs 1,6±0,3 ml/mm Hg (p<0,05).
Conclusion: Vascular function proved to be altered in patients with angina
and normal coronary arteries versus control subjects. These findings suggest a
possible pathophysiological link between large arteries stiffening, increased
afterload and angina symptoms, in the absence of coronary stenoses.
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Objective: To evaluate the performance and acceptance of the Screening
CardioVascular Lab (SCVL®, GenNov) as a screening and follow-up tool for
peripheral arterial disease (PAD) in the general practitioner's (GP) office. This
electronic device combines the oscillometric determination of the ankle-bra-
chial index (ABI) and the Edinburgh questionnaire (EQ).
Method: In a cross sectional study, 102 Belgian GPs recruited 505 patients
of 50 years, hospitalized within the last year for any ischemic event. The
electronic case report form was included in the SCVL®. 
Results: The patients were 69±11 years old (m±SD); men were 63%. Their
other CVR factors were: hypertension in 75%; dyslipidemia in 74%; seden-
tarily in 53%; abdominal obesity in 52%; familial history of CVD in 38%;
smoking in 28%; diabetes in 22%. The arterial events, which induced the
recent hospitalizations, were: acute in 71% of cases, planned for revascular-
ization in 23%; coronary in 50%, cerebral in 29%, aortic/peripheral in 15%.
For at least their hospitalization, 95% of patients were treated with antithrom-
botics, including 88% with antiplatelets. At the GP visit, PAD was previously
diagnosed by Doppler ultrasonography or arteriography in 13% of them. The
SCVL® returned the ABIs in 3±1 minutes. The patient ABI was of 0.95±0.20.
The EQ was positive, meaning a symptomatic PAD, in 16% of patients; the
patient ABI, < 0.90 in 37%; their combination, abnormal in 44%. The test sen-
sitivity increased from 64% for the single determination of the patient ABI to
79% for its combination with the EQ, while the specificity decreased from 67
to 61%. The GPs considered the SCVL® as easy-to-use with a score of 76±24/
100 and those experienced with handheld Doppler preferred the SCVL® with
a score of 73±30/100.
Conclusion: By automating combination of the oscillometric ABI and of
the Edinburgh questionnaire, the SCVL® emerges as an efficient and easy-to-
use device for the screening and follow-up of PAD by the GPs.
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Objective: To improve arterial rigidity in coronary patients
Methods: 48 coronary patients: 57 yrs; 15% women were compared with
16 volunteers: 51 yrs. Patients were included in a 4-week ambulatory educa-
tional program consisted of 22 meetings of cardiac rehabilitation, a therapeutic
and dietetic education and drugs adaptation following european recommanda-
tions. Patients and volunteers were examined at the beginning (Day 0 and 1),
at the end of the program (M1) and at 6 months. Brachial (average of 3 mea-
surements by OMRON M4) and central BP, pulse wave velocity (Sphyg-
mocor), heart rate, cholesterol, weight, smoking addiction and drug intake
were analysed by the same nurse. BP and PWV measurements at D1 were
used as baseline values. Percentage of variation for PWV between D1 and M1
for the volunteers was 6%.
Results: At M6 vs D1, patients risk factors were improved: total choles-
terol <5 mmol/l: 89 vs 50%, BP-140/90 mmHg: 96 vs 81%, smoking addic-
tion: 12.5 vs 15%, obesity (BMI>30): 15 vs 19%, diabete: 6% and
recommended treatment: 58% with beta blockers:79%, Aspirin: 100%, Statin:
96%, ACEI or sartan: 75%
Table – Results
Heart rate did not change significantly. The most important parameter to
explain the decrease of patients PWV was central BP after multiple regression.
Treatment did not significantly modify PWV, nor smoking addiction or total
cholesterol control (Student t test).
Conclusion: The education in a health network improved CV risk factors
and recommended treatment but also arterial rigidity in a few weeks. This
improvement was maintained although BP increased at M6 and heart rate did
not change during the study. This depends probably on an intrinsic improve-
ment of arterial rigidity of these coronary patients
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Objectives: the aims of our study were to assess the prevalence of signif-
icant lower limb arterial stenosis in a population of patients with an increased
cardiovascular risk and also to determine the best ankle brachial index
threshold value for its detection.
Methods: In patients with treated hypertension and/or another cardiovas-
cular risk factor (dyslipidemia, current smoking, diabetes), ankle brachial
index was measured using an automated oscillometric device with 2 synchro-
nized cuffs. The presence of atherosclerotic plaques was assessed indepen-
dently by a Doppler/ultrasound exam.
Results: We included 201 patients. Fifty two percent were men, of 58
±13,4 years old. Fifty 6 percent were treated for hypertension, 72% had dys-
lipidemia and 23% were treated for diabetes. There was 21% of current
smokers and 33% of previous smokers. A clinical peripheral arterial disease
was noted in 7% of the patients and the presence of a femoral stenosis >50%
in 7.7%. The prevalence of an ankle brachial index <0,9 was 19,7% and
16.6% for an ankle brachial index <0,85. The ankle brachial index perfor-
mance to detect a significant femoral plaque or a clinical peripheral arterial
disease is detailed in the table. The best predictors of the presence a peripheral
arterial disease or a significant plaque are one of the 3 following ankle bra-
chial index values: <0,85 or >1,30 or missing signal.
Conclusion: In patients with increased cardiovascular risk, the prevalence
of a significant inferior limb stenosis is 7.7%. The ankle brachial index is
easily and quickly measured by the automated SCVL® device. Our study
attests the feasibility of this approach to detect peripheral arterial disease and
arterial stenosis in daily practice in this population. 
Patients results: (mean) D1 M1 M6
Brachial BP (mmHg) 119/68 114/66* vs D1 122/69* vs M1
Central BP (mmHg) 110/69 106/66*vs D1 112/69*vs M1
PWV (m/s) 9.76 9.40*vs D1 9.42vs D1 (p: 0.057)
Volunteers results: (mean) D1 M1
Brachial BP (mmHg) 116/70 115/69
PWV (m/s) 8.6 8.8
